Putney Financial Group’s Dare Bioscience DARE Stock Holding History

Putney Financial Group’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1	Buy	+1	New	+$1	﹤0.01%	299
2025 Q3	–	Sell	-1	Closed	-$2	–	128
2025 Q2	$2	Hold	1	–	–	﹤0.01%	293
2025 Q1	$3	Hold	1	–	–	﹤0.01%	280
2024 Q4	$3	Buy	+1	New	+$3	﹤0.01%	304

Other funds holding DARE

Garde Capital Seattle, Washington $1.8B AUM 11.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFS Advisors Overland Park, Kansas $332M AUM 8.56% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Compass Financial Management Tampa, Florida $926M AUM

Putney Financial Group's DARE Position: Q3 2026 in Review

Putney Financial Group opened a new position in Dare Bioscience (DARE) in Q3 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #299 among its holdings. This is a return to the name: Putney Financial Group previously reported a position in DARE as recently as Q2 2025.

Putney Financial Group first reported a position in DARE in Q4 2024 and has held it in 4 quarters since. The position peaked at $3 in Q1 2025. 8 funds tracked by Wall St. Rank hold DARE as of Q3 2026.

Putney Financial Group held 1 share of Dare Bioscience worth $1 as of Q3 2026.
Dare Bioscience was a new Putney Financial Group position in Q3 2026.
Dare Bioscience made up ﹤0.01% of Putney Financial Group's portfolio in Q3 2026, its #299 holding.
Putney Financial Group first reported a position in Dare Bioscience in Q4 2024 and has held it in 4 quarters since.
Putney Financial Group's Dare Bioscience position peaked at $3 in Q1 2025.
8 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2026.

Based on Putney Financial Group's 13F filing for Q3 2026, filed 30 Oct 2026.